Conferees relieve policing agency of role in approving pain drugs.
Older Americans Report, November, 2005
In what advocates for palliative care are calling a victory for consumers, House and Senate conferees agreed last week to take back an authority Congress gave the Drug Enforcement Administration last year to review the way new pain medications are labeled and promoted.
The DEA's authority in this arena was attached to last year's budget for the Justice Department at the request of appropriations panel Chairman Frank Wolf (R-Va.). As restated this year, the measure would have "prevent[ed] DEA from establishing a procurement quota for a new drug containing a controlled substance unless the DEA has reviewed and publicly commented on the labeling, promotion, risk management plans and other documents for new drug applications."
Dan Scandling, a spokesman...
Most Recent Business Articles
- Multiple criteria evaluation and optimization of transportation systems
- Multi-criteria analysis procedure for sustainable mobility evaluation in urban areas
- A two-leveled multi-objective symbiotic evolutionary algorithm for the hub and spoke location problem
- Multi-criteria analysis for evaluating the impacts of intelligent speed adaptation
- The development of Taiwan arterial traffic-adaptive signal control system and its field test: a Taiwan experience
Most Recent Business Publications
Most Popular Business Articles
- 7 tips for effective listening: productive listening does not occur naturally. It requires hard work and practice - Back To Basics - effective listening is a crucial skill for internal auditors
- FAS 109: a primer for non-accountants - Financial Accounting Standards Board's "Statement 109: Accounting for Income Taxes"
- LIFO vs. FIFO: a return to the basics
- Design a commission plan that drives sales - Sales Commissions
- Too Young to Rent a Car? - 25-years-old the minimum age for car renting - Brief Article
